New offerings meet the growing demand for products to transport temperature-sensitive cell and gene therapies with Peli BioThermal announcing a wider range of products for frozen and deep frozen applications
Peli BioThermal, the global name in temperature controlled packaging, announces expanded dry ice shipper options to support exponential growth in cell and gene therapy shipments worldwide, as well as continued need to transport pandemic payloads. Payload capacities range from 1.1 litres to 179 litres and cover temperature ranges of minus 65 degrees Celsius to minus 20 degrees Celsius.
“Cell and gene therapies are highly individualised and patient-centric, which creates a drastically different supply chain than we see for mass-produced pharmaceutical products,” said Greg Wheatley, Vice President of Worldwide New Product Development and Engineering at Peli BioThermal. “This supply chain introduces individuals who are not always familiar with cold chain packaging. Our job is to make easy-to-use temperature controlled solutions for these applications.”
Peli BioThermal’s expanded range of dry ice parcels can replace liquid nitrogen systems on short journeys that include a courier. The easy-to-pack parcels are available in single-use Sherpa Systems™ and DeepFreeze™ shippers, as well as the reusable Crēdo Cube™ shippers. The Sherpa Systems shippers range in size from 5 litres to 179 litres, DeepFreeze products are available in 1.1 litre to 8 litre sizes, and Crēdo Cube shippers include 5 litre and 17 litre sizes.
Sherpa Systems use Expanded Polystyrene (EPS) insulation and are molded with density to achieve required performance standards. DeepFreeze and Crēdo Cube shippers, by contrast, feature high-performance VIP (vacuum insulated panels) that protect the payload and require less dry ice, lowering transportation costs. Dry ice products provide frozen payload protection with durations from 96 hours to 225 hours.
All three systems are cost-effective and easy to pack-out compared to other dry ice frozen shipping products. Additionally, Peli BioThermal shippers undergo constant stress tests in ambient temperatures of 30 degrees Celsius to ensure the payload remains within temperature range for expected durations.
Peli BioThermal continues to work on utilising dry ice in even more platforms to continue providing solutions for payload protection of temperature sensitive shipments. For more information about Peli BioThermal’s dry ice parcel offerings, visit https://pelibiothermal.com/thermal-packaging/dry-ice-parcel or go to www.pelibiothermal.com to learn more about the wide range of Peli BioThermal products and offerings.
Peli BioThermal is a division of Peli Products, S.L.U., which is the European arm of Pelican Products, Inc., which is a portfolio company of Behrman Capital, a private equity investment firm based in New York and San Francisco.
About Peli BioThermal
Peli BioThermal offers the widest range of temperature-controlled packaging and service solutions to the global life sciences industry. The company’s products ensure that delicate biological materials arrive intact and effective, despite exterior environments. Peli BioThermal is dedicated to developing innovative products designed to fulfill the complex needs of the global life sciences industry. Peli BioThermal’s customers benefit from its extensive expertise in ensuring that temperature stability is maintained throughout the distribution chain. The company also offers a complete portfolio of services and software to support end-to-end temperature-controlled packaging asset management. Peli BioThermal is a division of Pelican Products, Inc., the global leader in the design and manufacture of high-performance protective cases, advanced portable lighting systems and rugged gear for professionals and outdoor enthusiasts. For more information, visit pelibiothermal.com.
All trademarks are registered and/or unregistered trademarks of Pelican Products, Inc., its parent, subsidiaries and/or affiliates.